Senior Scientist I, Cancer Immunology
Revolution Medicines
October 2, 2026
Full-time
On-site
San Francisco Bay Area
Clinical Research and Development
Role: Immuno-oncology researcher within Revolution Medicines' Cancer Immunology team, focusing on preclinical and clinical biomarker development for RAS-addicted cancers. Responsibilities: design and execute in vitro, in vivo, ex vivo studies; evaluate emerging technologies; drive reverse translational research to inform clinical strategies; stay current with tumor immunology advances; communicate findings internally and externally. Requirements: Ph.D. in immunology, cancer biology, or related field; 4+ years industry experience in oncology drug discovery; expertise in tumor immunology, immune biomarkers, and immunotherapy; proficiency in in vivo models, flow cytometry, functional assays, and molecular biology; strong analytical, problem-solving, and communication skills. Preferred: experience with humanized mouse models, multiomics, and computational analysis. High-Value: focus on immuno-oncology, biomarker discovery, mechanistic studies, early-stage development. WorkSetup: onsite in Redwood City, CA, salary range $149K-$186K, with competitive total rewards.